Neuroinflammation was truly identified as an essential component of the pathophysiology of stroke in the mid- to late 1990s [53–55], although the identification of TSPO glial expression was originally described after cerebral ischaemia, when TSPO was still referred to as the peripheral benzodiazepine receptor [56, 7]. Here, TSPO is linked to Stroke.